Published in Arch Dermatol on April 01, 2009
Unusual causes of cutaneous ulceration. Surg Clin North Am (2010) 1.06
Calciphylaxis: a severe complication of renal disease. CMAJ (2011) 1.04
Update on cutaneous calciphylaxis. Indian J Dermatol (2013) 0.96
A case report: radiological findings in an unusual case of calciphylaxis 16 years after renal transplantation. Skeletal Radiol (2013) 0.82
Calcific Uremic Arteriolopathy Revisited. J Am Soc Nephrol (2016) 0.75
Sodium thiosulfate in the treatment of calciphylaxis. J Clin Aesthet Dermatol (2013) 0.75
Bisphosphonate-associated osteonecrosis of the jaw: are we dealing with a localized non-traditional calciphylaxis? Open Dent J (2012) 0.75
Calciphylaxis in the absence of renal failure and hyperparathyroidism in a nonagenarian. BMJ Case Rep (2015) 0.75
Sodium thiosulfate for the treatment of warfarin-induced calciphylaxis in a nondialysis patient. J Pharmacol Pharmacother (2016) 0.75
[Calciphylaxis. A less well-known, clinically relevant disease]. Pathologe (2011) 0.75
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 6.85
Development of sarcoidosis in cosmetic tattoos. Arch Dermatol (2005) 2.44
Vascular inflammation (vasculitis) in sweet syndrome: a clinicopathologic study of 28 biopsy specimens from 21 patients. Arch Dermatol (2002) 1.84
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol (2011) 1.74
Tissue eosinophilia: not an indicator of drug-induced subacute cutaneous lupus erythematosus. Arch Dermatol (2011) 1.53
Clinically relevant information about cutaneous lupus erythematosus. Arch Dermatol (2009) 1.51
Cutaneous manifestations of internal malignancy. CA Cancer J Clin (2009) 1.51
Sweet's syndrome in a patient with enterococcal subacute bacterial endocarditis. J Am Acad Dermatol (2004) 1.46
Thwarting a killer. Am J Med (2006) 1.40
Recalcitrant tinea corporis as the presenting manifestation of patch-stage mycosis fungoides. Cutis (2003) 1.38
Cutaneous dermatomyositis: an updated review of treatment options and internal associations. Am J Clin Dermatol (2013) 1.20
Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol (2009) 1.17
Necrotizing peripheral vasculitis/vasculopathy following the use of cocaine laced with levamisole. J Burn Care Res (2012) 1.12
Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma. Dermatol Ther (2010) 1.12
Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol (2006) 1.11
Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-λ and IgA-κ gammopathy following treatment of a nodal plasmacytoma. Arch Dermatol (2011) 1.10
Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure. Arch Dermatol (2010) 1.09
Calcinosis cutis complicating adult-onset dermatomyositis. Arch Dermatol (2004) 1.09
Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. Arch Dermatol (2006) 1.09
Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol (2006) 1.07
American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol (2004) 1.03
Fluoroscopy-induced chronic radiation skin injury: a disease perhaps often overlooked. Arch Dermatol (2007) 1.03
Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol (2012) 1.02
Multicentric reticulohistiocytosis successfully treated with infliximab: an illustrative case and evaluation of cytokine expression supporting anti-tumor necrosis factor therapy. Arch Dermatol (2008) 1.01
Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis. J Invest Dermatol (2002) 1.00
Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol (2002) 1.00
Mycophenolate mofetil as therapy for pyoderma gangrenosum. Arch Dermatol (2009) 0.94
Subcutaneous panniculitis-like T-cell lymphoma with vacuolar interface dermatitis resembling lupus erythematosus panniculitis. J Am Acad Dermatol (2004) 0.91
Tazarotene is an effective therapy for elastosis perforans serpiginosa. Arch Dermatol (2002) 0.91
Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol (2006) 0.91
Multicentric reticulohistiocytosis in a 14-year-old girl. Pediatr Dermatol (2002) 0.91
Phenylephrine-induced microvascular occlusion syndrome in a patient with a heterozygous factor V Leiden mutation. Arch Dermatol (2007) 0.90
Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. J Invest Dermatol (2002) 0.89
Successful use of rituximab for cutaneous vasculitis. Arch Dermatol (2006) 0.88
Acute-onset, painful acral granuloma annulare: a report of 4 cases and a discussion of the clinical and histologic spectrum of the disease. Arch Dermatol (2006) 0.88
Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol Oncol (2006) 0.86
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study. Int J Gynecol Cancer (2014) 0.86
Management of neutrophilic dermatoses. Dermatol Ther (2012) 0.85
Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol (2002) 0.85
Glomeruloid hemangioma leading to a diagnosis of POEMS syndrome. J Am Acad Dermatol (2006) 0.85
AAD consensus statement on psoriasis therapies. J Am Acad Dermatol (2003) 0.84
Paget disease in a man. Arch Dermatol (2008) 0.84
Leukaemia cutis in a patient treated for breast cancer. Australas J Dermatol (2009) 0.84
The cutting edge: Thalidomide for type 1 cryoglobulinemic vasculopathy. Arch Dermatol (2006) 0.84
Ioversol-induced acute generalized exanthematous pustulosis: a case report. Arch Dermatol (2009) 0.84
Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate. J Am Acad Dermatol (2004) 0.83
Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy. Arch Dermatol (2010) 0.82
Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil. Arch Dermatol (2009) 0.82
When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol (2002) 0.81
Azathioprine: a guide for the management of dermatology patients. Dermatol Ther (2007) 0.81
Atypical herpes simplex infection masquerading as recalcitrant pemphigus vulgaris. Australas J Dermatol (2007) 0.80
Atypical fibroxanthoma with regional lymph node metastasis: report of a case and review of the literature. Arch Dermatol (2010) 0.80
Systematic reviews: grading recommendations and evidence quality. Arch Dermatol (2008) 0.80
Hydroxyurea-induced dermatomyositis-like eruption. J Am Acad Dermatol (2003) 0.80
Common pediatric and adolescent skin conditions. J Pediatr Adolesc Gynecol (2003) 0.79
Pyoderma gangrenosum Preceding the diagnosis of systemic lupus erythematosus. Dermatology (2005) 0.79
Generalized eruptive histiocytosis. J Am Acad Dermatol (2004) 0.79
Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands. Arch Dermatol (2009) 0.79
Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum. Arch Dermatol (2004) 0.78
Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia. J Am Acad Dermatol (2005) 0.78
Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis. Int J Dermatol (2006) 0.78
Dermatologic comorbidities of diabetes mellitus and related issues. Arch Dermatol (2009) 0.77
Early-onset obesity and risk for psoriatic arthritis. JAMA (2010) 0.77
Myopathy induced by antimalarial agents: the relevance of screening muscle enzyme levels. Arch Dermatol (2009) 0.77
Bupropion-induced subacute cutaneous lupus erythematosus. Australas J Dermatol (2005) 0.77
The use of B vitamins for cutaneous ulcerations mimicking pyoderma gangrenosum in patients with MTHFR polymorphism. Arch Dermatol (2011) 0.77
Sweet-like dermatosis in 2 patients with clinical features of dermatomyositis and underlying autoimmune disease. Arch Dermatol (2008) 0.76
Color Doppler sonography of endometrial masses. J Ultrasound Med (2002) 0.76
Prevention of osteoporosis associated with chronic glucocorticoid therapy. JAMA (2006) 0.76
Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin. Gynecol Oncol (2006) 0.76
Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients. J Drugs Dermatol (2010) 0.75
A new day for "On the Horizon". Arch Dermatol (2005) 0.75
Vaginal cells of smokers are more resistant to human papillomavirus infection than that of non-smokers. Exp Mol Pathol (2012) 0.75
The importance of a name. JAMA Dermatol (2013) 0.75
Clinical trial registration: a step forward in providing transparency for the positive and negative results of clinical trials. Arch Dermatol (2005) 0.75
Use of antibiotics and risk of cancer. JAMA (2004) 0.75
African tick bite fever: a not-so-uncommon illness in international travelers. Arch Dermatol (2006) 0.75
How frequently are drugs associated with the development or exacerbation of subacute cutaneous lupus? Arch Dermatol (2003) 0.75
Rhinophymalike swelling in an 86-year-old woman. Primary cutaneous B-cell lymphoma of the nose. Arch Dermatol (2004) 0.75
Consider drugs as a cause or an exacerbating factor in patients diagnosed with subacute cutaneous lupus erythematosus! Br J Dermatol (2012) 0.75
Calcinosis cutis: an additional therapy to consider. J Am Acad Dermatol (2012) 0.75
Therapy-related leukaemia cutis: a review. Australas J Dermatol (2008) 0.75
Nonhealing ulcer secondary to factor V Leiden mutation and cryofibrinogenemia. J Am Acad Dermatol (2004) 0.75
Hydroxyurea-induced leg ulceration in a patient with a homozygous MTHFR polymorphism misdiagnosed as pyoderma gangrenosum. JAMA Dermatol (2014) 0.75
Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil. Arch Dermatol (2012) 0.75
Clinical characteristics of patients with prolonged disease-free survival after primary treatment in advanced ovarian cancer: a brief report. Int J Gynecol Cancer (2011) 0.75
www.archdermatol.com communicates with the international dermatology community. Arch Dermatol (2005) 0.75
Farewell to the evidence-based dermatology section. JAMA Dermatol (2014) 0.75
Acral psoriasiform eruption in a man with squamous cell carcinoma of the tonsillar pillar. Arch Dermatol (2005) 0.75
Golimumab-exacerbated subacute cutaneous lupus erythematosus. Arch Dermatol (2012) 0.75
Neonatal lupus erythematosus mimicking langerhans cell histiocytosis. Pediatr Dermatol (2003) 0.75
Resident rounds. Part III. Erosive and desquamative syphilis associated with mucositis in the setting of acquired immune deficiency syndrome. J Drugs Dermatol (2011) 0.75
Biotechnology succeeds in revolutionizing medical science. Arch Dermatol (2005) 0.75
Incontinentia pigmenti presenting as seizures. Pediatr Dermatol (2002) 0.75
The journal name: representing worldwide instant accessibility. Arch Dermatol (2012) 0.75
Generalized linear IgA dermatosis with palmar involvement. Dermatol Online J (2015) 0.75
Introducing Misha Rosenbach, MD, section editor for JAMA Dermatology patient page. JAMA Dermatol (2013) 0.75
Cutaneous lymphoproliferative disorder complicating infectious mononucleosis in an immunosuppressed patient. Pediatr Dermatol (2011) 0.75
Dystrophic calcinosis cutis in pseudoxanthoma elasticum. J Am Acad Dermatol (2008) 0.75